ESET, LLC v. Finjan, Inc.

Track this case

Case Number:

19-1716

Court:

Appellate - Federal Circuit

Nature of Suit:

- 

Companies

Sectors & Industries:

  1. May 15, 2020

    COVID-19 IP Catch-Up: Source Code Woes, Generic Antivirals

    The Federal Circuit will continue to hold remote oral arguments into the summer, Gilead is allowing some generic-drug makers to produce versions of its antiviral treatment remdesivir, and companies that are allegedly upcharging for coronavirus-related products are continuing to find themselves in court for trademark law violations.

  2. May 11, 2020

    Finjan Holds Onto Antivirus Patent In Fight With ESET

    The Federal Circuit on Monday upheld a Patent Trial and Appeal Board decision that ESET LLC failed to prove that a Finjan computer antivirus patent is invalid, dismissing ESET's argument that it faced "undeserved prejudice" from the board, a claim Finjan called "simply nonsense."